These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5763842)

  • 1. Effect of reserpine in Raynaud's phenomenon.
    Kontos HA; Wasserman AJ
    Circulation; 1969 Feb; 39(2):259-66. PubMed ID: 5763842
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous microcirculation in systemic sclerosis and response to intra-arterial reserpine.
    Nilsen KH; Jayson MI
    Br Med J; 1980 Jun; 280(6229):1408-11. PubMed ID: 7427134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-arterial reserpine for Raynaud's syndrome. Systemic reactions without therapeutic benefit.
    Surwit RS; Gilgor RS; Duvic M; Allen LM; Neal JA
    Arch Dermatol; 1983 Sep; 119(9):733-5. PubMed ID: 6614959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of raynaud's disease and phenomenon with intraarterial reserpine (author's transl)].
    González Folch M; Saffie F
    Rev Med Chil; 1976 Jan; 104(1):21-4. PubMed ID: 788084
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sympatholytic effect of intra-arterial reserpine in sclerodermia and Raynaud's disease].
    Acevedo A; Palacios JM; López R; Palma F
    Rev Med Chil; 1984 Jun; 112(6):553-8. PubMed ID: 6515168
    [No Abstract]   [Full Text] [Related]  

  • 6. Reserpine treatment of Raynaud's disease.
    Nobin BA; Nielsen SL; Eklov B; Lassen NA
    Ann Surg; 1978 Jan; 187(1):12-6. PubMed ID: 619795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intra-arterial reserpine in Raynaud's disease and syndrome].
    Arcas Meca R; Ono Okabe S; Barroso-Moguel R; Quijano Pitman F
    Arch Inst Cardiol Mex; 1972; 42(2):260-8. PubMed ID: 5028993
    [No Abstract]   [Full Text] [Related]  

  • 8. Intra-arterial administration of reserpine. Its use in patients with Raynaud's disease or Raynaud's phenomenon.
    Romeo SG; Whalen RE; Tindall JP
    Arch Intern Med; 1970 May; 125(5):825-9. PubMed ID: 5444311
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of intra-arterial reserpine in patients suffering from Raynaud's phenomenon.
    Acevedo A; Reginato AJ; Schnell AM
    J Cardiovasc Surg (Torino); 1978; 19(1):77-84. PubMed ID: 627597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid crystal thermography: a measure of therapeutic response to reserpine given intra-arterially.
    Chandler C
    South Med J; 1976 May; 69(5):614-5. PubMed ID: 1273622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reserpine and Raynaud's phenomenon.
    Gifford RW
    N Engl J Med; 1971 Jul; 285(5):290-1. PubMed ID: 5090401
    [No Abstract]   [Full Text] [Related]  

  • 12. Reserpine in Raynaud's phenomenon.
    Lancet; 1970 Aug; 2(7670):454. PubMed ID: 4195127
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical uses of intra-arterial injections of reserpine. Treatment of Raynaud syndrome and of some vascular insufficiencies of the lower extremities.
    Tindall JP; Whalen RE; Burton EE
    Arch Dermatol; 1974 Aug; 110(2):233-7. PubMed ID: 4604746
    [No Abstract]   [Full Text] [Related]  

  • 14. Hematemesis after reserpine for Raynaud's phenomenon.
    Sharon E; Paolino JS; Kaplan D
    Ann Intern Med; 1972 Sep; 77(3):479-80. PubMed ID: 5053741
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of intra-arterial ketanserin in Raynaud's phenomenon assessed by 99MTc-pertechnetate scintigraphy.
    Kunnen JJ; Dahler HP; Doorenspleet JG; van Oene JC
    Eur J Clin Pharmacol; 1988; 34(3):267-71. PubMed ID: 2840293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raynaud's disease and phenomenon, a medical approach.
    Willerson JT; Decker JL
    Am Heart J; 1971 Oct; 82(4):572-3. PubMed ID: 5111239
    [No Abstract]   [Full Text] [Related]  

  • 17. Intraarterial reserpine administration in Raynaud syndrome.
    McFadyen IJ; Housley E; MacPherson AI
    Arch Intern Med; 1973 Oct; 132(4):526-8. PubMed ID: 4742406
    [No Abstract]   [Full Text] [Related]  

  • 18. Cold-induced changes in plasma norepinephrine, epinephrine and dopamine concentrations in patients with Raynaud's phenomenon.
    Marasini B; Biondi ML; Mollica R; Del Santo A; Agostoni A
    Eur J Clin Chem Clin Biochem; 1991 Feb; 29(2):111-4. PubMed ID: 2049479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reserpine in Raynaud's disease and phenomenon. Short-term response to intra-arterial injection.
    Willerson JT; Thompson RH; Hookman P; Herdt J; Decker JL
    Ann Intern Med; 1970 Jan; 72(1):17-27. PubMed ID: 5410395
    [No Abstract]   [Full Text] [Related]  

  • 20. The mechanisms of Raynaud's phenomenon: Part 1.
    McGrath MA; Penny R
    Med J Aust; 1974 Aug; 2(9):328-33. PubMed ID: 4422091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.